Cargando…

Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria

Anaerobes play an important role in clinically relevant infections and resistance is increasing worldwide. We tested 120 rare anaerobic isolates belonging to 16 genera for antimicrobial resistance using the agar dilution method and compared those results to the time-saving E-test method. The suscept...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Lena Josephine, Stingu, Catalina-Suzana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854874/
https://www.ncbi.nlm.nih.gov/pubmed/36671264
http://dx.doi.org/10.3390/antibiotics12010063
_version_ 1784873236324941824
author Wolf, Lena Josephine
Stingu, Catalina-Suzana
author_facet Wolf, Lena Josephine
Stingu, Catalina-Suzana
author_sort Wolf, Lena Josephine
collection PubMed
description Anaerobes play an important role in clinically relevant infections and resistance is increasing worldwide. We tested 120 rare anaerobic isolates belonging to 16 genera for antimicrobial resistance using the agar dilution method and compared those results to the time-saving E-test method. The susceptibility data for 12 antimicrobial substances (benzylpenicillin, ampicillin/sulbactam, piperacillin/tazobactam, imipenem, meropenem, cefoxitin, metronidazole, moxifloxacin, clindamycin, doxycycline, tigecycline, eravacycline) were collected. Susceptibility testing showed low resistance to β-lactam/β-lactamase inhibitor combinations and no resistance to carbapenems and tigecycline. We observed moderate to high rates of resistance to moxifloxacin and clindamycin which differed depending on the methodology used. The essential and categorical agreement was over 90% for ampicillin/sulbactam, meropenem, moxifloxacin, and tigecycline. For metronidazole and clindamycin, the essential agreement was below 90% but the categorical agreement was near or above 90%. Penicillin presented with the lowest categorical agreement of 86.7% and a very high very major error rate of 13.3%. The resistance rates reported in this study are concerning and show the importance of routine susceptibility testing. Further investigations are necessary to determine the reason for high error rates and how to improve susceptibility testing of fastidious anaerobes.
format Online
Article
Text
id pubmed-9854874
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98548742023-01-21 Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria Wolf, Lena Josephine Stingu, Catalina-Suzana Antibiotics (Basel) Article Anaerobes play an important role in clinically relevant infections and resistance is increasing worldwide. We tested 120 rare anaerobic isolates belonging to 16 genera for antimicrobial resistance using the agar dilution method and compared those results to the time-saving E-test method. The susceptibility data for 12 antimicrobial substances (benzylpenicillin, ampicillin/sulbactam, piperacillin/tazobactam, imipenem, meropenem, cefoxitin, metronidazole, moxifloxacin, clindamycin, doxycycline, tigecycline, eravacycline) were collected. Susceptibility testing showed low resistance to β-lactam/β-lactamase inhibitor combinations and no resistance to carbapenems and tigecycline. We observed moderate to high rates of resistance to moxifloxacin and clindamycin which differed depending on the methodology used. The essential and categorical agreement was over 90% for ampicillin/sulbactam, meropenem, moxifloxacin, and tigecycline. For metronidazole and clindamycin, the essential agreement was below 90% but the categorical agreement was near or above 90%. Penicillin presented with the lowest categorical agreement of 86.7% and a very high very major error rate of 13.3%. The resistance rates reported in this study are concerning and show the importance of routine susceptibility testing. Further investigations are necessary to determine the reason for high error rates and how to improve susceptibility testing of fastidious anaerobes. MDPI 2022-12-29 /pmc/articles/PMC9854874/ /pubmed/36671264 http://dx.doi.org/10.3390/antibiotics12010063 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wolf, Lena Josephine
Stingu, Catalina-Suzana
Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria
title Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria
title_full Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria
title_fullStr Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria
title_full_unstemmed Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria
title_short Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria
title_sort antimicrobial susceptibility profile of rare anaerobic bacteria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854874/
https://www.ncbi.nlm.nih.gov/pubmed/36671264
http://dx.doi.org/10.3390/antibiotics12010063
work_keys_str_mv AT wolflenajosephine antimicrobialsusceptibilityprofileofrareanaerobicbacteria
AT stingucatalinasuzana antimicrobialsusceptibilityprofileofrareanaerobicbacteria